Venus Remedies Balance Sheet Annual

Trade

BSE: 526953 | NSE: VENUSREM | ISIN: INE411B01019 | Sector: Biotechnology & Drugs

299.90 +7.85 (2.69%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	19.14	30.00	2.05	-
Cash Equivalents	48.96	21.21	43.26	28.88
Short Term Investments	19.83	20.13	0.48	0.28
Cashand Short Term Investments	87.93	71.34	45.80	29.16
Accounts Receivable- Trade Net	80.50	76.66	38.60	32.04
Total Receivables Net	110.48	125.52	67.11	60.76
Total Inventory	121.69	122.92	125.64	119.99
Other Current Assets Total	39.43	2.50	39.49	24.13
Total Current Assets	359.53	322.96	278.04	234.03
Property/ Plant/ Equipment Total- Gross	21.08	364.06	-	-
Property/ Plant/ Equipment Total- Net	154.40	162.81	178.24	190.08
Intangibles Net	85.21	79.25	87.93	96.72
Long Term Investments	5.25	-	2.19	1.93
Other Long Term Assets Total	22.44	36.06	33.42	33.09
Total Assets	626.83	601.08	579.82	555.85
Accounts Payable	44.15	50.84	54.29	71.36
Current Portof LT Debt/ Capital Leases	2.65	0.00	0.10	0.18
Other Currentliabilities Total	32.62	22.10	34.29	21.60
Total Current Liabilities	79.42	82.57	92.74	97.45
Long Term Debt	38.68	38.68	38.68	46.83
Total Long Term Debt	38.68	38.68	38.68	46.83
Total Debt	41.33	42.29	42.85	51.32
Deferred Income Tax	10.92	10.65	0.00	3.63
Other Liabilities Total	10.26	8.85	7.95	7.66
Total Liabilities	139.28	140.74	139.37	155.57
Common Stock Total	13.37	13.37	13.37	12.34
Retained Earnings( Accumulated Deficit)	474.18	353.59	427.08	387.94
Total Equity	487.55	460.34	440.45	400.28
Total Liabilities Shareholders' Equity	626.83	601.08	579.82	555.85
Total Common Shares Outstanding	1.34	1.34	1.34	1.23
Tangible Book Valueper Share Common Eq	300.93	285.10	263.72	245.96
Prepaid Expenses	-	0.67	-	-
Accumulated Depreciation Total	-	-227.34	-	-
Accrued Expenses	-	6.02	-	-
Notes Payable/ Short Term Debt	-	3.61	4.06	4.31
Additional Paid- In Capital	-	88.33	-	-
Other Equity Total	-	5.05	-	-